Nine PDX models carried an activating PIK3CA mutation: 5 ER+, 1 HER2+ and 3 triple-negative tumors, 2 of them established from metaplastic breast cancers (details on PIK3CA mutations are provided in Figure 1 legend). This evidence concerns the gene ERBB2 and breast cancer.